GSK Submits EMA Regulatory Application For Malaria Vaccine
July 24 2014 - 6:45AM
Dow Jones News
LONDON--GlaxoSmithKline PLC (GSK.LN) Thursday said it submitted
a regulatory application to the European Medicines Agency for its
experimental malaria vaccine.
A "positive opinion" from the EMA would move GSK a step closer
to marketing the RTS,S vaccine to individual countries in
sub-Saharan Africa.
Shares at 1012 GMT down 9 pence or 0.6% at 1,472 pence.
Write to Ed Ballard at ed.ballard@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
GSK (NYSE:GSK)
Historical Stock Chart
From May 2023 to May 2024